Scientific Program

Scientific Program

Thursday, May 23, 2013

14.00 – 14.05

Welcome Address: Helmut Kettenmann

14.05 - 15.20

Session I
Chair: Manfred Westphal

14.05 – 14.45

 

Plenary I
Peter Canoll
Pathology & Cell Biology, College of Physicians and Surgeons, Columbia University, New York, USA
Tracking gliomagenesis: From glial progenitor to proneural glioma
 

14.45 – 15.05

Oral Presentation I
Joerg Bartsch
Neurosurgery, Philipps-University Marburg, Marburg, Germany
A critical role for the metalloprotease-disintegrin adam8 in glioma growth
 

15.05 - 15.25

Oral Presentations II
Axel Pagenstecher
Neuropathology, University of Marburg, Marburg, Germany
The assay medium is the message: in cns tissue the gpi-anchored mmp17 and mmp25 are the most potent mt-mmp-mediators of the astrocyte
 

15.25 – 16.00

Poster Session and Coffee Break

16.00 – 17.20

Session II
Chair: Darko Markovic

16.00 – 16.40

 

Plenary II
Michael Weller
Klinik für Neurologie, UniversitätsSpital Zürich
Personalized medicine for glioblastoma: facts and fictions
 

16.40 - 17.00

Oral Presentation III
Paolo Malatesta
DIMES, University of Genova, Italy
Targeting malignant gliomas with engineered herpes virus
 

17.00 – 17.20

Oral Presentation IV
Stefanie Robel
Neurobiology, University of Alabama at Birmingham (UAB), USA
The role of reactive astrocytes in glioma associated epilepsy
 

17.20 – 17.50

Coffee Break and Poster Session

17.50 – 19.10

Session III
Chair: Christel Herold-Mende

17.50 – 18.30

 

Plenary III
Ruggero De Maria
Istituto Regina Elena, Rome, Italy
Targeting cancer stem cells in glioblastoma
 

18.30 – 18.50

Oral Presentation V
Johannes vom Berg
Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland
Local interleukin-12 in combination with systemic checkpoint blockade leads to t-cell dependent rejection of advanced stage glioma
 

18.50 – 19.10

Oral Presentation VI
Rolf Mentlein
Anatomy, University of Kiel, Germany
Functional role of transmembrane chemokines in gliomas
 

19.20 – 20.00

Bus Transfer to Berlin Museum of Medical History / Charité

20.00

Reception in the Berlin Museum of Medical History / Charité

 

Friday, May 24, 2013

9.00 - 10.00

Session IV
Chair: Rainer Glass

9.00 - 9.40

 

Plenary IV
Gabriele Bergers
University of California, Departments of Neurological Surgery and Anatomy,
San Francisco, USA
VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex
 

9.40 - 10.00

Oral Presentation VII
Roland Kälin
Department of Neuropathology, Charité – Universitätsmedizin Berlin, Germany
Dissecting the role of apelin signaling in gliomagenesis
 

10.00 – 10.40

Poster Session and Coffee Break

10.40 – 11.40
Session V
Chair: Jürgen Kiwit

10.40 – 11.20

 

Plenary V
Bozena Kaminska
Nencki Institute of Experimental Biology, Department of Cell Biology,
Warsaw, Poland
Molecular mechanisms driving pro-tumorigenic polarization of microglia in gliomas
 

11.20 – 11.40

Oral Presentation VIII
Susanne Kleber
Department of Molecular Neurobiology (A290), German Cancer Research Centre (DKFZ), Heidelberg
CD95 in tumor initiation an progression
 

11.40 – 12.30

Lunch

12.30 – 15.50

Session VI
Chair: Frank Heppner

12.30 – 13.10

 

Plenary VI
Peter Vajkoczy
Klinik und Poliklinik für Neurochirurgie, 
Charité - Campus Virchow-Klinikum, Berlin
Microglia home to the perivascular niche
and contribute to angiogenesis in brain tumors
 

13.10 – 13.50

 

Plenary VII
Michael Platten
Neurologische Klinik, Neuroonkologie, Universtätsklinikum Heidelberg
The immunosuppressive microenvironment in gliom

13.50 – 14.10

Coffee Break

14.10 – 14.50

 

Plenary VIII
Hui Zong
Department of Microbiology, Immunology, and Cancer Biology, Center for Cell Signaling,
University of Virginia School of Medicine, Charlottesville, VA 22908-0577, USA
Understanding tumor cell maneuvers in brain tumors with MADM,
a genetic mosaic system

15.00

Departure

 

Sponsors